These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1657080)

  • 1. Phase II study of pirarubicin in untreated metastatic small cell lung carcinoma. Groupe Français de Pneumo-Cancérologie (GFPC).
    Kleisbauer JP; Vergeret J; Balmes P; Reynaud-Gaubert M; Taytard A; Targhetta R; Thomas P; Bonnaud F; Poirier R
    Eur J Cancer; 1991; 27(7):943. PubMed ID: 1657080
    [No Abstract]   [Full Text] [Related]  

  • 2. Pirarubicin phase II study in untreated metastatic small-cell lung carcinoma. A cooperative study of the Groupe Français de Pneumo-Cancérologie (GFPC).
    Kleisbauer JP; Vergeret J; Balmes P; Arnaud A; Taytard A; Targhetta R; Thomas P; Bonnaud F; Poirier R; Touron D
    Am J Clin Oncol; 1990; 13 Suppl 1():S20-3. PubMed ID: 1963272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A phase II trial of pirarubicin in untreated disseminated small cell lung cancer. A cooperative study of the French Pneumo-Cancerology Group].
    Kleisbauer JP; Taytard A; Balmes P; Reynaud-Gaubert M; Vergeret J; Targhetta R; Thomas P; Bonnaud F; Poirier R
    Rev Mal Respir; 1992; 9(2):179-84. PubMed ID: 1314404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin-mitomycin and vindesine in the treatment of inoperable non-small cell lung cancer groupe français de pneumo-cancérologie (GFPC).
    Thomas P; Kleisbauer JP; Perol M; Taytard A; Poirier R; Le Caer H; Guerin JC; Bonnaud F; Balmes P; Carles P
    Eur J Cancer; 1993; 29A(3):477. PubMed ID: 8398353
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II trial of paclitaxel and carboplatin in metastatic small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie study.
    Thomas P; Castelnau O; Paillotin D; Léna H; Robinet G; Muir JF; Delaval P; Gouva S; Balmes P; Blanchon F; Perdu D; Poirier R; Pommier De Santi P; Penot-Ragon C; Kleisbauer JP
    J Clin Oncol; 2001 Mar; 19(5):1320-5. PubMed ID: 11230474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects for pirarubicin.
    Miller AA; Salewski E
    Med Pediatr Oncol; 1994; 22(4):261-8. PubMed ID: 8107658
    [No Abstract]   [Full Text] [Related]  

  • 7. [High-dose ifosfamide in patients with stage IV non-small cell lung cancer: phase II trial from the Groupe français de pneumo-cancérologie (GFPC)].
    Vergnenègre A; Thomas P; Robinet G; Pibarot M; Paillotin D; Vernejoux JM; Thiberville L; Lena H; Kleisbauer JP; Gimonet JF
    Bull Cancer; 1999 Dec; 86(12):1017-21. PubMed ID: 10660695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of pirarubicin in advanced non-small cell lung cancer.
    Berthaud P; Le Chevalier T; Berille J; Herait P; Baldeyrou P; Tursz T; Arriagada R; Spielmann M; Hayat M
    Eur J Cancer Clin Oncol; 1989 Oct; 25(10):1507-8. PubMed ID: 2556281
    [No Abstract]   [Full Text] [Related]  

  • 9. Second-line oral chemotherapy (lomustine, cyclophosphamide, etoposide) versus intravenous therapy (cyclophosphamide, doxorubicin, and vincristine) in patients with relapsed small cell lung cancer: a randomized phase II study of GFPC 0501.
    Gervais R; Le Caer H; Monnet I; Falchero L; Baize N; Olivero G; Thomas P; Berard H; Auliac JB; Chouaid C;
    Clin Lung Cancer; 2015 Mar; 16(2):100-5. PubMed ID: 25467927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer. A phase II trial conducted by the Groupe Francais de Pneumo-Cancerologie (GFPC).
    Vergnenègre A; Daniel C; Léna H; Fournel P; Kleisbauer JP; Le Caer H; Letreut J; Paillotin D; Pérol M; Bouchaert E; Preux PM; Robinet G;
    Lung Cancer; 2005 Mar; 47(3):395-404. PubMed ID: 15713523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II evaluation of triazinate in patients with metastatic lung cancer.
    Creagan ET; Eagan RT; Fleming TR; Frytak S; Ingle JN; Kvols LK; Nichols WC
    Cancer Treat Rep; 1980; 64(10-11):1057-9. PubMed ID: 6257389
    [No Abstract]   [Full Text] [Related]  

  • 12. [New anthracycline analogues in the treatment of lung cancer].
    Ueoka H; Ohnoshi T; Kimura I
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2146-9. PubMed ID: 1332624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of the combination of carboplatin and ifosfamide in previously untreated metastatic small cell lung carcinoma.
    Le Chevalier T; Thomas F; Subirana R; Baldeyrou P; Ruffie P; Arriagada R; Chazard M; Tursz T
    Cancer; 1991 Jun; 67(12):2980-3. PubMed ID: 1646067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pirarubicin in advanced non-small cell lung cancer. A trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer Society.
    Drings P; Günther IU; Gatzemeier U; Berdel W; Stahl M; Salewski E; Edler L
    Onkologie; 1990 Jun; 13(3):180-4. PubMed ID: 2168533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study.
    Fournel P; Robinet G; Thomas P; Souquet PJ; Léna H; Vergnenégre A; Delhoume JY; Le Treut J; Silvani JA; Dansin E; Bozonnat MC; Daurés JP; Mornex F; Pérol M;
    J Clin Oncol; 2005 Sep; 23(25):5910-7. PubMed ID: 16087956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts.
    Breistøl K; Hendriks HR; Berger DP; Langdon SP; Fiebig HH; Fodstad O
    Eur J Cancer; 1998 Sep; 34(10):1602-6. PubMed ID: 9893636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A randomized phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin and adriamycin in combination with vincristine and ACNU in small cell lung cancer--THP-ADM, VCR, ACNU vs ADM, VCR, ACNU].
    Hino M; Kobayashi K; Kurane S; Nukariya N; Yamano Y; Hasegawa K; Tsuboi E; Niitani H
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3143-8. PubMed ID: 2551250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of esorubicin in patients with advanced non-small cell lung cancer.
    Kris MG; Gralla RJ; Burke MT; Fiore JJ; Kelsen DP; Marks LD; Heelan RT
    Cancer Treat Rep; 1987; 71(7-8):783-4. PubMed ID: 3038319
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer.
    Conley BA; Hornedo J; Abrams J; Eisenberger M; Hiponia D; Aisner J; Van Echo DA
    Cancer Treat Rep; 1987 Sep; 71(9):861-2. PubMed ID: 3040246
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug resistance in medical oncology.
    Zijlstra JG; de Vries EG; Mulder NH
    Neth J Med; 1987 Feb; 30(1-2):85-93. PubMed ID: 3035391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.